Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease

Clinical trial NCT05572996 · AVAILABLE

Trial details

NCT number: NCT05572996
Sponsor: Ferrer Internacional S.A.
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Pulmonary Hypertension Interstitial Lung Disease Combined Pulmonary Fibrosis and Emphysema

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.